封面
市场调查报告书
商品编码
1532636

行为復健市场 - 按疾病类型(焦虑、情绪、药物滥用、个性、注意力不足过动症)、医疗保健环境(住院、住院、门诊)、治疗(咨商、药物) - 全球预测(2024 - 2032)

Behavioral Rehabilitation Market - By Disorder Type (Anxiety, Mood, Substance Abuse, Personality, Attention Deficit Disorders), Healthcare Setting (Inpatient, Residential, Outpatient), Treatment (Counselling, Medication) - Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在技​​术和个人化治疗整合的推动下,2024年至2032年全球行为復健市场的复合年增长率将达到5.9%。人工智慧驱动的平台和数位健康解决方案等先进技术提高了復健服务的有效性和可及性。这些创新使得量身订製的治疗计画能够满足个人需求和偏好,进而改善患者的治疗效果。随着技术的发展和个人化方法变得更加普遍,它们提供了更精确、更有效率、更有吸引力的康復体验,从而扩大了市场并满足寻求心理健康支持的人们的多样化需求。

例如,2023 年 9 月,Discovery Behavioral Health, Inc. 推出了 Discovery365,这是一个与 Videra Health 和一家领先的研究医院共同开发的人工智慧驱动平台,旨在解决「一年的康復差距」。这一发展凸显了技术在精神健康保健中的日益融合,旨在缩小「一年恢復差距」并改善患者的治疗结果。此类创新解决方案的推出凸显了行为復健领域向更个人化和数据驱动的方法的转变,有可能提高治疗效果并扩大市场机会。

行为復健行业根据疾病类型、医疗保健环境、治疗和地区进行分类。

由于忧郁症和躁郁症等疾病的高盛行率和重大影响,到 2032 年,情绪障碍细分市场将经历显着改善。这些疾病通常需要广泛且持续的復健服务,包括治疗、药物管理和支持计划。人们对心理健康问题的日益认识和对专门治疗方案的需求不断增加,有助于情绪障碍的市场主导地位。随着意识和治疗选择的不断扩大,这一领域可能会推动市场的大幅成长。

由于药物在管理各种心理健康状况方面发挥着至关重要的作用,其在 2024 年至 2032 年间将显着增长。抗忧郁药物、抗精神病药物和情绪稳定剂等药物对于治疗情绪障碍、焦虑和其他精神疾病至关重要。它们在缓解症状和改善患者治疗效果方面的有效性推动了高需求。随着越来越多的人寻求药物治疗作为康復过程的一部分,药物治疗仍然是精神健康保健的主要组成部分。

由于该地区人口的快速增长和人们对心理健康问题的认识不断提高,亚太地区行为復健市场将在 2024 年至 2032 年间获得显着的份额。扩大医疗基础设施和增加可支配收入有助于更多地获得行为健康服务。此外,旨在改善精神卫生保健的文化转变和政府措施进一步促进了市场成长。随着该地区继续投资心理健康资源和服务,亚太地区将脱颖而出,成为全球行为復健产业的关键贡献者。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 行为和心理健康的意识和措施不断增强
      • 心理健康和行为健康障碍盛行率上升
      • 越来越多地采用远距医疗和线上咨询服务
    • 产业陷阱与挑战
      • 低收入和中等收入国家的服务成本较高
      • 行为障碍的社会和文化限制
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 未来市场趋势
  • 復健的数位演变:当前趋势和未来方向
  • 启动场景
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按疾病类型,2021 - 2032 年

  • 主要趋势
  • 焦虑症
  • 情绪障碍
  • 药物滥用障碍
  • 人格障碍
  • 注意力缺陷障碍
  • 其他疾病类型

第 6 章:市场估计与预测:按医疗保健环境,2021 - 2032 年

  • 主要趋势
  • 住院病人
  • 住宅
  • 门诊

第 7 章:市场估计与预测:按处理方法,2021 - 2032

  • 主要趋势
  • 辅导
  • 药物
  • 支援服务
  • 其他治疗方法

第 8 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 9 章:公司简介

  • AAC Holdings, Inc.
  • Acadia Healthcare Company, Inc.
  • Behavioral Health Group (BHG)
  • Caron Treatment Centers
  • Elements Behavioral Health
  • Foundations Recovery Network
  • Futures Recovery Healthcare
  • Hazelden Betty Ford Foundation
  • Lakeview Health
  • Landmark Recovery
  • Newport Academy
  • Promises Behavioral Health
  • Springstone, Inc.
  • The Priory Group
  • Universal Health Services, Inc.
简介目录
Product Code: 9702

Global Behavioral Rehabilitation Market will exhibit 5.9% CAGR from 2024 to 2032, fueled by the integration of technology and personalization of treatment. Advanced technologies, such as AI-driven platforms and digital health solutions, enhance the effectiveness and accessibility of rehabilitation services. These innovations enable tailored treatment plans that address individual needs and preferences, improving patient outcomes. As technology evolves and personalized approaches become more prevalent, they offer more precise, efficient, and engaging rehabilitation experiences, thus expanding the market and meeting the diverse needs of those seeking mental health support.

For instance, in September 2023, Discovery Behavioral Health, Inc. launched Discovery365, an AI-driven platform developed with Videra Health and a leading research hospital, to address the "one year recovery gap." This development highlights the growing integration of technology in mental health care, aiming to bridge the "One Year Recovery Gap" and improve patient outcomes. The introduction of such innovative solutions underscores a shift towards more personalized and data-driven approaches in behavioral rehabilitation, potentially enhancing treatment efficacy and expanding market opportunities.

The behavioral rehabilitation industry is classified based on disorder type, healthcare setting, treatment, and region.

The mood disorders segment will experience a marked upturn through 2032 due to the high prevalence and significant impact of conditions such as depression and bipolar disorder. These disorders often require extensive and ongoing rehabilitation services, including therapy, medication management, and support programs. The growing recognition of mental health issues and the increasing demand for specialized treatment options contribute to the dominant market position of mood disorders. As awareness and treatment options continue to expand, this segment will likely drive substantial market growth.

The medication segment will observe a noteworthy surge between 2024 and 2032, driven by its crucial role in managing various mental health conditions. Medications such as antidepressants, antipsychotics, and mood stabilizers are essential in treating mood disorders, anxiety, and other psychiatric conditions. Their effectiveness in alleviating symptoms and improving patient outcomes drives high demand. As more individuals seek pharmacological treatments as part of their rehabilitation process, the medication segment remains a dominant and integral component of mental health care.

Asia Pacific behavioral rehabilitation market will achieve a remarkable share from 2024 to 2032, attributed to the region's rapidly growing population and increasing awareness of mental health issues. Expanding healthcare infrastructure and rising disposable incomes contribute to greater access to behavioral health services. Additionally, cultural shifts and government initiatives aimed at improving mental health care further boost market growth. As the region continues to invest in mental health resources and services, Asia Pacific will stand out as a pivotal contributor to the global behavioral rehabilitation industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing awareness and initiatives for behavioral and mental health
      • 3.2.1.2 Rise in prevalence of mental health and behavioral health disorders
      • 3.2.1.3 Increasing adoption of telemedicine and online counseling services
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of services in low- and middle-income countries
      • 3.2.2.2 Social and cultural constraints for behavioral disorders
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Future market trends
  • 3.7 Digital evolution of rehabilitation: current trends and future directions
  • 3.8 Start-up scenario
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Disorder Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Anxiety disorders
  • 5.3 Mood disorders
  • 5.4 Substance abuse disorders
  • 5.5 Personality disorders
  • 5.6 Attention deficit disorders
  • 5.7 Other disorder types

Chapter 6 Market Estimates and Forecast, By Healthcare Setting, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Inpatient
  • 6.3 Residential
  • 6.4 Outpatient

Chapter 7 Market Estimates and Forecast, By Treatment Method, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Counselling
  • 7.3 Medication
  • 7.4 Support services
  • 7.5 Other treatment methods

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AAC Holdings, Inc.
  • 9.2 Acadia Healthcare Company, Inc.
  • 9.3 Behavioral Health Group (BHG)
  • 9.4 Caron Treatment Centers
  • 9.5 Elements Behavioral Health
  • 9.6 Foundations Recovery Network
  • 9.7 Futures Recovery Healthcare
  • 9.8 Hazelden Betty Ford Foundation
  • 9.9 Lakeview Health
  • 9.10 Landmark Recovery
  • 9.11 Newport Academy
  • 9.12 Promises Behavioral Health
  • 9.13 Springstone, Inc.
  • 9.14 The Priory Group
  • 9.15 Universal Health Services, Inc.